# IQVIA HOLDINGS INC. (IQV) · Edgar & Edgarette company card

> Iqvia Holdings (IQV) grew revenue 5.9% in FY2025 to $16.3 billion, operating margin 13.4% against a 14.9% median for commercial physical & biological research, equity 21.7% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1478242 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/IQV) · [JSON](https://www.pops4.com/boards/company/IQV.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $16.3B |
| Revenue growth, 1 year | 5.9% |
| Revenue growth per year | 4.1% |
| Operating margin | 13.4% (prior year 14.3%) |
| Net margin | 8.3% |
| Operating cash flow | $2.7B |
| Capital spending | $603M |
| Free cash flow | $2.1B |
| Cash | $2.0B |
| Long-term debt | $15.7B |
| Total assets | $29.9B |
| Total equity | $6.5B |
| Equity ÷ assets | 21.7% |
| Return on equity | 20.9% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 1.13 (grey zone)
- Piotroski F: 5 of 9 (middling)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $16.3B (FY2025), total debt $15.7B. Experience: revenue up 5.9% on the year, up 4.1% a year over 4 years; operating margin 13.4%, down from 14.3%. Soundness: equity 21.7% of assets, return on equity 20.9%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $15.5B and $17.7B next year (method v4.1: its own 4-year record of growth weighed at 50% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $14.7B to $18.6B. A statistical range, not company guidance. Against peers (8 filers, $50M+ revenue, its industry group): operating margin 13.4% against a 14.9% median; growth 5.9% against 5.2%.

Range logged 2026-09-26, receipt 32a2c3d70bda9791, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-04-23 ([filing](https://www.sec.gov/Archives/edgar/data/1478242/000119312526173771/0001193125-26-173771-index.htm))

## Recent filings

- 10-Q · filed 2026-10-27 · [filing](https://www.sec.gov/Archives/edgar/data/1478242/000162828026067646/0001628280-26-067646-index.htm)
- 8-K · filed 2026-10-27 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1478242/000162828026067406/0001628280-26-067406-index.htm)
- 8-K · filed 2026-09-23 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1478242/000119312526399616/0001193125-26-399616-index.htm)
- 8-K · filed 2026-09-09 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1478242/000119312526386633/0001193125-26-386633-index.htm)
- 10-Q · filed 2026-07-28 · [filing](https://www.sec.gov/Archives/edgar/data/1478242/000162828026050211/0001628280-26-050211-index.htm)
- 8-K · filed 2026-07-28 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1478242/000162828026049923/0001628280-26-049923-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001478242.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1478242

## Cite

POPS4, Edgar & Edgarette: IQVIA HOLDINGS INC. (IQV) company card, from the company's own SEC filings, accessed 2026-11-05, https://www.pops4.com/boards/company/IQV. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.